氧化在体外循环过程中的脏保护作用:一项实验研究
Nikolay O Kamenshchikov1, Yuri K Podoksenov1, Boris N Kozlov1
1Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 111a Kievskaya St., Tomsk 634012, Russia.
Biomedicines
|June 27, 2024
概括
在心肺绕道 (CPB) 期间使用氧化 (NO) 有效地减少了损伤和线粒体功能障碍. 这种NO疗法被证明是安全的,提供了一种有希望的方法来保护CPB手术期间的脏.
科学领域:
- 心血管外科心血管外科
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物医学工程 生物医学工程
背景情况:
- 心肺绕道 (CPB) 可以导致损伤,线粒体功能障碍和调节的细胞死亡.
- 在CPB期间保护功能是一个关键的临床挑战.
研究的目的:
- 为了评估80ppm氧化 (NO) 在缓解损伤,线粒体功能障碍和细胞死亡的有效性,在实验CPB.
- 评估NO2和甲血球蛋白水平的NO2管理的安全性.
主要方法:
- 24只羊接受了CPB,或没有低温循环停止 (CA),接受80ppmNO或假治疗.
- 损伤通过中性粒细胞凝酶相关性脂卡林 (NGAL) 水平和组织学分析进行评估.
- 在脏组织中评估了线粒体功能和亡/亡标志物 (TNF-α) 的表达.
主要成果:
- NO的使用并没有显著增加吸入的NO2或甲血球蛋白水平.
- 与假装组相比,没有NO调节的组显示损伤和线粒体功能障碍减少.
- CPB + NO 组显示损伤的统计显著减少,而 CPB + CA + NO 组减少了TNF-α表达.
结论:
- 以80ppm的氧化 (NO) 给药在实验CPB期间减少损伤是安全有效的.
- NO疗法显示出缓解线粒体功能障碍和在CPB后脏组织中调节细胞死亡的潜力.
更多相关视频
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
23.6K
08:12Normothermic Ex Vivo Kidney Perfusion for the Preservation of Kidney Grafts prior to Transplantation
Published on: July 15, 2015
19.1K
相关概念视频
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Antihypertensive Drugs: Vasodilators
503
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
503
